1 year return (CAGR)
-25.22%
Myriad Genetics Inc Exchange (NASDAQ, USD)
MYGN
6.35
+0.20 (+3.44%)
HealthcareDiagnostics & Research
Loading...
3 year return (CAGR)
-25.67%
5 year return (CAGR)
-28.46%
10 year return (CAGR)
-10.68%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
575.81M
Price/Sales
0.71
Ent value
795.61M
Price/Book
1.89
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
62.26%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.82 |
| Daily high | 6.07 |
| Daily low | 5.78 |
| Daily Volume | 1.48M |
| All-time high | 61.27 |
| 1y analyst estimate | 3.91 |
| Beta | 1.68 |
| EPS (TTM) | -1.19 |
| Dividend per share | 0.00 |
| Ex-div date | 1 Jul 2009 |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MYGN | S&P500 | |
| Current price drop from All-time high | -89.64% | -3.00% |
| Highest price drop | -95.33% | -56.47% |
| Date of highest drop | 31 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -61.61% | -10.65% |
| Avg time to new high | 150 days | 12 days |
| Max time to new high | 6530 days | 1805 days |
News
